Press Releases
Pfizer to Acquire King Pharmaceuticals, Inc.
Pfizer Inc.and King Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement. Under the terms of the agreement, Pfizer will acquire King, a diversified specialty pharmaceutical discovery and clinical development company, for $3.6 billion in cash,...
Press Releases
ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the reporting of positive interim clinical data with trastuzumab-DM1 (T-DM1) for first-line treatment of HER2+ metastatic breast cancer in a press release issued by the European...
Press Releases
AJ Precision Components to Exhibit at Interplas 2011
AJ Precision Components will be exhibiting at Interplas 2011 from 27 to 29 September. Come and visit us on stand A58 in hall 4 at the NEC Birmingham, UK.
Press Releases
APR and Labtec enter into exclusive License Agreement with Ferrer International
APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion, distribution and marketing of Donepezil Oral Dispersible Film (ODF) in Spain, Portugal and Germany....
Press Releases
Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
Baxter International Inc. announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES). The vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults...
Press Releases
Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
Baxter International Inc. announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES). The vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults...
Press Releases
Johnson & Johnson Completes Acquisition of Micrus Endovascular
Johnson & Johnson announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke.  Johnson & Johnson announced its agreement to acquire Micrus on July 12,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read